News
-
-
PRESS RELEASE
Iute Group Reports Unaudited Results for 12M/2025 Transformation into Digital Bank Ongoing
Iute Group reports unaudited 12M/2025 results, continuing transformation into digital bank. Revenue growth, decreased cost of risk, and successful bond refinancing. CEO & CFO to discuss results in webcast -
-
-
PRESS RELEASE
BioVersys and partners’ phase 2a tuberculosis trial results published in New England Journal of Medicine
BioVersys and partners demonstrate promising results with AlpE in Phase 2a tuberculosis trial, published in New England Journal of Medicine. AlpE shows potential in treating drug-resistant tuberculosis -
-
-
-
-